These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27964757)

  • 1. Discordant inflammation and pain in early and established rheumatoid arthritis: Latent Class Analysis of Early Rheumatoid Arthritis Network and British Society for Rheumatology Biologics Register data.
    McWilliams DF; Ferguson E; Young A; Kiely PD; Walsh DA
    Arthritis Res Ther; 2016 Dec; 18(1):295. PubMed ID: 27964757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register.
    McWilliams DF; Walsh DA
    BMC Musculoskelet Disord; 2016 Aug; 17():337. PubMed ID: 27515300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining Changes in Central and Peripheral Pain as Mediates of Fatigue Improvement: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Jones GT; Macfarlane GJ; Basu N
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):922-6. PubMed ID: 26605992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining Pathways to Improvements in Fatigue in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Jones GT; Macfarlane GJ; Basu N
    Arthritis Rheumatol; 2015 Sep; 67(9):2303-10. PubMed ID: 26108189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of Clinically Relevant Clusters of Severe Fatigue in Rheumatoid Arthritis.
    Basu N; Jones GT; Macfarlane GJ; Druce KL
    Psychosom Med; 2017; 79(9):1051-1058. PubMed ID: 28570437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
    Pan Y; Norton S; Gwinnutt JM; Kearsley-Fleet L; Symmons DPM; Lunt M; Young A; ; Hyrich KL; Verstappen SMM
    PLoS One; 2019; 14(5):e0215999. PubMed ID: 31107887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA.
    Hamann PDH; Pauling JD; McHugh N; Hyrich K; Shaddick G;
    Rheumatology (Oxford); 2020 Jul; 59(7):1709-1714. PubMed ID: 31714580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrete Trajectories of Resolving and Persistent Pain in People With Rheumatoid Arthritis Despite Undergoing Treatment for Inflammation: Results From Three UK Cohorts.
    McWilliams DF; Dawson O; Young A; Kiely PDW; Ferguson E; Walsh DA
    J Pain; 2019 Jun; 20(6):716-727. PubMed ID: 30658176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
    Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
    Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.
    Brennan A; Bansback N; Nixon R; Madan J; Harrison M; Watson K; Symmons D
    Rheumatology (Oxford); 2007 Aug; 46(8):1345-54. PubMed ID: 17562686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of rituximab in patients with rheumatoid arthritis: observational study from the British Society for Rheumatology Biologics Register.
    Soliman MM; Hyrich KL; Lunt M; Watson KD; Symmons DP; Ashcroft DM;
    J Rheumatol; 2012 Feb; 39(2):240-6. PubMed ID: 22174201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.
    Pease C; Pope JE; Truong D; Bombardier C; Widdifield J; Thorne JC; Paul Haraoui B; Psaradellis E; Sampalis J; Bonner A
    Semin Arthritis Rheum; 2011 Aug; 41(1):81-9. PubMed ID: 21168187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunistic infections in rheumatoid arthritis patients exposed to biologic therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Rutherford AI; Patarata E; Subesinghe S; Hyrich KL; Galloway JB
    Rheumatology (Oxford); 2018 Jun; 57(6):997-1001. PubMed ID: 29529307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study.
    McWilliams DF; Zhang W; Mansell JS; Kiely PD; Young A; Walsh DA
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1505-13. PubMed ID: 22556121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Bhattacharya Y; Jones GT; Macfarlane GJ; Basu N
    Rheumatology (Oxford); 2016 Oct; 55(10):1786-90. PubMed ID: 27330158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
    Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
    Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
    J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Jones GT; Macfarlane GJ; Basu N
    Rheumatology (Oxford); 2015 Jun; 54(6):964-71. PubMed ID: 25313148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
    Gerber LH; Furst G; Yarboro C; el-Gabalawy H
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.